{
    "organizations": [],
    "uuid": "71abc0e458191131356ab3e37346bed8e4d2417d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-clementias-treatment-with-palovaro/brief-clementias-treatment-with-palovarotene-significantly-reduces-new-bone-growth-in-patients-with-fop-idUSFWN1SU0DO",
    "ord_in_thread": 0,
    "title": "BRIEF-Clementia's Treatment With Palovarotene Significantly Reduces New Bone Growth In Patients With FOP",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 23 (Reuters) - Clementia Pharmaceuticals Inc:\n* CLEMENTIA REPORTS POSITIVE PHASE 2 PART B DATA SHOWING TREATMENT WITH PALOVAROTENE SIGNIFICANTLY REDUCES NEW BONE GROWTH IN PATIENTS WITH FOP\n* PHASE 2 PART B DATA SHOW EVALUABLE PATIENTS WITH NO NEW BONE AT 12 WEEKS HAD NO NEW BONE AT 12 MONTHS\n* STATISTICALLY SIGNIFICANT 91% REDUCTION OF NEW HO AT FLARE-UP SITES AT 12 WEEKS; 65% REDUCTION OF NEW HO AT 12-MONTH WBCT SCAN IN PHASE 2 DATA\n* PALOVAROTENE GENERALLY WELL-TOLERATED IN TRIAL, CONSISTENT WITH EXPERIENCE ACROSS PALOVAROTENE CLINICAL STUDIES\n* RECENTLY SURPASSED ENROLLMENT OF FIRST 35 PATIENTS IN OUR PHASE 3 MOVE TRIAL, ON TRACK TO COMPLETE STUDY ENROLLMENT BY YEAR END\n* ON TRACK TO REPORT FIRST INTERIM ANALYSIS FOR MOVE TRIAL IN MID-2019 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-23T19:06:00.000+03:00",
    "crawled": "2018-05-24T20:16:49.005+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "clementia",
        "pharmaceutical",
        "inc",
        "clementia",
        "report",
        "positive",
        "phase",
        "part",
        "b",
        "data",
        "showing",
        "treatment",
        "palovarotene",
        "significantly",
        "reduces",
        "new",
        "bone",
        "growth",
        "patient",
        "fop",
        "phase",
        "part",
        "b",
        "data",
        "show",
        "evaluable",
        "patient",
        "new",
        "bone",
        "week",
        "new",
        "bone",
        "month",
        "statistically",
        "significant",
        "reduction",
        "new",
        "ho",
        "site",
        "week",
        "reduction",
        "new",
        "ho",
        "wbct",
        "scan",
        "phase",
        "data",
        "palovarotene",
        "generally",
        "trial",
        "consistent",
        "experience",
        "across",
        "palovarotene",
        "clinical",
        "study",
        "recently",
        "surpassed",
        "enrollment",
        "first",
        "patient",
        "phase",
        "move",
        "trial",
        "track",
        "complete",
        "study",
        "enrollment",
        "year",
        "end",
        "track",
        "report",
        "first",
        "interim",
        "analysis",
        "move",
        "trial",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}